SCHEMBL12377823

SCHEMBL12377823

Cc1cccc(-c2nn(C(C)C)c(=O)o2)c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NOTUM Q6P988 1/20 0.49
NPC1 O15118 5/20 0.46
RAB9A P51151 5/20 0.46
HPGD P15428 4/20 0.46
SMN1; SMN2 Q16637 3/20 0.46
TSHR P16473 1/20 0.46
ALDH1A1 P00352 2/20 0.42
TP53 P04637 2/20 0.42
HSD17B10 Q99714 2/20 0.42
POLB P06746 1/20 0.42
KDM4E B2RXH2 5/20 0.42
PBRM1 Q86U86 1/20 0.42
SRC P12931 1/20 0.41
CA1 P00915 1/20 0.41
CA2 P00918 1/20 0.41
FAAH O00519 1/20 0.40
MAPT P10636 2/20 0.38
GRIN1 Q05586 1/20 0.38
GRIN2B Q13224 1/20 0.38
MAOB P27338 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12377820 0.80 NOTUM (0.55) NOTUMNPC1RAB9AHPGDSMN1; SMN2
SCHEMBL12377822 0.77 IL2 (0.49) NOTUMNPC1RAB9AHPGDSMN1; SMN2
SCHEMBL12377830 0.75 NOTUM (0.45) NOTUMNPC1RAB9AHPGDSMN1; SMN2
SCHEMBL12377829 0.73 GRIN1 (0.47) NOTUMNPC1RAB9AHPGDSMN1; SMN2
SCHEMBL12377825 0.73 GRIN1 (0.47) NOTUMNPC1RAB9AHPGDSMN1; SMN2
SCHEMBL12377833 0.72 GAA (0.47) NOTUMNPC1RAB9AHPGDSMN1; SMN2
SCHEMBL12377828 0.71 GRIN1 (0.46) NOTUMNPC1RAB9AHPGDSMN1; SMN2
SCHEMBL12377824 0.71 NOTUM (0.47) NOTUMNPC1RAB9AHPGDSMN1; SMN2
SCHEMBL12377827 0.70 CNR1 (0.47) NOTUMNPC1RAB9AHPGDSMN1; SMN2
SCHEMBL9186057 0.70 NOTUM (0.43) NOTUMNPC1RAB9AHPGDSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7998954-B2 Pyrimidodiazepinone derivative KYOWA HAKKO KIRIN CO., LTD. (JP) 2011-08-16 US disclosed
US-7998954-B2 Pyrimidodiazepinone derivative KYOWA HAKKO KIRIN CO., LTD. (JP) 2011-08-16 US disclosed
US-20100190775-A1 PYRIMIDODIAZEPINONE DERIVATIVE KYOWA HAKKO KIRIN CO., LTD (JP) 2010-07-29 US disclosed
US-20100190775-A1 PYRIMIDODIAZEPINONE DERIVATIVE KYOWA HAKKO KIRIN CO., LTD (JP) 2010-07-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100190775-A1 PYRIMIDODIAZEPINONE DERIVATIVE KCNJ1, KCNJ11, ADRA1D NOTUM 3182/4885NPC1 1132/4885RAB9A 2645/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.